Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The VEP and ERG in a young infant with cystic fibrosis. A case report.

Literature DB >> 10189182

The VEP and ERG in a young infant with cystic fibrosis. A case report.

Abstract

We report a case of an infant with cystic fibrosis in whom VEP and scotopic ERG abnormalities were found. The underlying cause of these findings, which could not be determined within the limitations of this study, may be related to dietary deficiencies.

Entities: Disease Gene Species

Mesh：

Year: 1998 PMID： 10189182 DOI： 10.1023/a:1001772327537

Source DB: PubMed Journal: Doc Ophthalmol ISSN： 0012-4486 Impact factor: 2.379

12 in total

1. Effects of behavioural state on visual processing in neonates.

Authors: P Apkarian; M Mirmiran; R Tijssen
Journal: Neuropediatrics Date: 1991-05 Impact factor: 1.947

2. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse.

Authors: C R Jones; T Arai; S I Rapoport
Journal: Neurochem Res Date: 1997-06 Impact factor: 3.996

3. Dark-adaptation testing for diagnosis of subclinical vitamin-A deficiency and evaluation of therapy.

Authors: R M Russell; V C Smith; R Multack; A E Krill; I H Rosenberg
Journal: Lancet Date: 1973-11-24 Impact factor: 79.321

4. Docosahexaenoic acid modulates the interactions of the interphotoreceptor retinoid-binding protein with 11-cis-retinal.

Authors: Y Chen; L A Houghton; J T Brenna; N Noy
Journal: J Biol Chem Date: 1996-08-23 Impact factor: 5.157

5. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids.

Authors: D G Birch; E E Birch; D R Hoffman; R D Uauy
Journal: Invest Ophthalmol Vis Sci Date: 1992-07 Impact factor: 4.799

6. Visual electrophysiology to achromatic and chromatic stimuli in premature and full term infants.

Authors: G A Rudduck; G F Harding
Journal: Int J Psychophysiol Date: 1994-05 Impact factor: 2.997

7. Dietary essential fatty acid supply and visual acuity development.

Authors: E E Birch; D G Birch; D R Hoffman; R Uauy
Journal: Invest Ophthalmol Vis Sci Date: 1992-10 Impact factor: 4.799

8. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma.

Authors: F R Smith; D S Goodman
Journal: J Clin Invest Date: 1971-11 Impact factor: 14.808

9. Development of visual acuity in relation to plasma and erythrocyte omega-6 and omega-3 fatty acids in healthy term gestation infants.

Authors: S M Innis; C M Nelson; M F Rioux; D J King
Journal: Am J Clin Nutr Date: 1994-09 Impact factor: 7.045

The VEP and ERG in a young infant with cystic fibrosis. A case report.

1. Effects of behavioural state on visual processing in neonates.

2. Evidence for the involvement of docosahexaenoic acid in cholinergic stimulated signal transduction at the synapse.

3. Dark-adaptation testing for diagnosis of subclinical vitamin-A deficiency and evaluation of therapy.

4. Docosahexaenoic acid modulates the interactions of the interphotoreceptor retinoid-binding protein with 11-cis-retinal.

5. Retinal development in very-low-birth-weight infants fed diets differing in omega-3 fatty acids.

6. Visual electrophysiology to achromatic and chromatic stimuli in premature and full term infants.

7. Dietary essential fatty acid supply and visual acuity development.

8. The effects of diseases of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma.

9. Development of visual acuity in relation to plasma and erythrocyte omega-6 and omega-3 fatty acids in healthy term gestation infants.

Review 10. Modulation of rhodopsin function by properties of the membrane bilayer.

1. Acquired subretinal flecks secondary to hypovitaminosis A in a patient with hepatitis C.

2. Role of electroretinography in the assessment of retinal function as an indicator of vitamin A status.

3. Lutein, zeaxanthin, macular pigment, and visual function in adult cystic fibrosis patients.

4. Lacrimal glands in cystic fibrosis.

5. ERGs in children with pancreatic enzyme insufficient and pancreatic enzyme sufficient cystic fibrosis.